Frédérich Michel, Tits Monique, Goffin Eric, Philippe Geneviève, Grellier Philippe, De Mol Patrick, Hayette Marie-Pierre, Angenot Luc
Natural and Synthetic Drug Research Center, Laboratory of Pharmacognosy, University of Liège, Avenue de l'hôpital 1,B36, 4000 Liège, Belgium.
Planta Med. 2004 Jun;70(6):520-5. doi: 10.1055/s-2004-827151.
Isostrychnopentamine (ISP) is an asymmetric indolomonoterpenic alkaloid isolated from the leaves of Strychnos usambarensis. The in vitro antiplasmodial activities against five Plasmodium falciparum cell lines were evaluated: ISP possessed an in vitro IC (50) near 0.1 microM against all P. falciparum cell lines tested (chloroquine-resistant and chloroquine-sensitive lines) and showed antiplasmodial selectivity compared to cytotoxicity on human cell lines. The stage-dependent susceptibility to a short exposure of ISP was then investigated. The ring stage was shown to be the most sensitive one, but all stages were affected by ISP treatment. By means of fluorescence microscopy, it was shown that ISP was not accumulated inside the food vacuole of the parasite. Finally, the in vivo antimalarial activities against the P. berghei NK173 and P. vinckei petteri murine strains were determined. The ED (50) in vivo was about 30 mg/kg/day by the intraperitoneal route (after 4 days treatment).
异马钱子五胺(ISP)是一种从乌干达马钱子叶中分离出的不对称吲哚单萜生物碱。评估了其对五种恶性疟原虫细胞系的体外抗疟活性:ISP对所有测试的恶性疟原虫细胞系(耐氯喹和氯喹敏感系)的体外半数抑制浓度(IC50)接近0.1微摩尔,与对人类细胞系的细胞毒性相比显示出抗疟选择性。随后研究了ISP短期暴露的阶段依赖性敏感性。环状体阶段显示为最敏感阶段,但所有阶段均受ISP处理的影响。通过荧光显微镜观察表明,ISP未在寄生虫的食物泡内积累。最后,测定了对伯氏疟原虫NK173和文氏疟原虫彼得里鼠株的体内抗疟活性。腹腔注射途径(治疗4天后)的体内半数有效剂量(ED50)约为30毫克/千克/天。